General Information of the Compound
Compound ID
CP0502023
Compound Name
1-[2-(2,4,6-trimethylphenyl)ethyl]pyrrolidine
    Show/Hide
Synonyms
1-[2-(2,4,6-trimethyl-phenyl)-ethyl]-pyrrolidine
CHEMBL272140
    Show/Hide
Structure
Formula
C15H23N
Molecular Weight
217.356
Canonical SMILES
Cc1cc(C)c(CCN2CCCC2)c(C)c1
    Show/Hide
InChI
InChI=1S/C15H23N/c1-12-10-13(2)15(14(3)11-12)6-9-16-7-4-5-8-16/h10-11H,4-9H2,1-3H3
    Show/Hide
InChIKey
IYOUBSBBWJSRIG-UHFFFAOYSA-N
Physicochemical Property
logP
3.25016
Rotatable Bonds
3
Heavy Atom Count
16
Polar Areas
3.24
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
1
Complexity
16

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44456331
ChEMBL ID
CHEMBL272140
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01194, Histamine H3 receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 400 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 1-[2-(2,4,6-trimethyl-phenyl)-ethyl]-pyrrolidine )
Drug Name 1-[2-(2,4,6-trimethyl-phenyl)-ethyl]-pyrrolidine
Target(s)
Histamine H3 receptor (H3R)
Inhibitor